# Montelukast

## SINGULAIR Chewable 5mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OSIN                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Indications        | SINGULAIR is indicated in adult & pediatric patients 6 months of age & older for the prophylaxis & chronic treatment of asthma， including the prevention of day- & nighttime symptoms， the treatment of aspirin-sensitive asthmatic patients， & the prevention of exercise-induced bronchoconstriction. SINGULAIR is indicated in adults & pediatric patients 2 years of age & older for the relief of day- & nighttime symptoms of seasonal allergic rhinitis.                                                                                 |
| Dosing             | Should be taken once daily. For asthma， the dose should be taken in the evening. For seasonal allergic rhinitis， the time of administration may be individualized. Patients with both asthma & seasonal allergic rhinitis should take only 1 TAB daily in the evening. Asthma and/or seasonal allergic rhinitis- Age > or = 15 years: 10 mg QD. Age 6-14 years: One 5 mg chewable TAB QD. Age 2-5 years: One 4 mg chewable TAB QD or one packet of 4 mg oral granules QD. Age 6 months-2 years with asthma: One packet of 4 mg oral granules QD. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Hypersensitivity to any component of Singulair.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | Abdominal pain， headache， thirst， diarrhea， hyperkinesia， asthma， eczematous dermatitis， rash. Neurologic: Headache (Adult and adolescent; 18.4%; pediatric， 2% and greater )                                                                                                                                                                                                                                                                                                                                                              |
| Pregnancy          | No (limited) human data – probably compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

## SINGULAIR 10mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OSIN1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Indications        | SINGULAIR is indicated in adult & pediatric patients 6 months of age & older for the prophylaxis & chronic treatment of asthma， including the prevention of day- & nighttime symptoms， the treatment of aspirin-sensitive asthmatic patients， & the prevention of exercise-induced bronchoconstriction. SINGULAIR is indicated in adults & pediatric patients 2 years of age & older for the relief of day- & nighttime symptoms of seasonal allergic rhinitis.                                                                                 |
| Dosing             | Should be taken once daily. For asthma， the dose should be taken in the evening. For seasonal allergic rhinitis， the time of administration may be individualized. Patients with both asthma & seasonal allergic rhinitis should take only 1 TAB daily in the evening. Asthma and/or seasonal allergic rhinitis- Age > or = 15 years: 10 mg QD. Age 6-14 years: One 5 mg chewable TAB QD. Age 2-5 years: One 4 mg chewable TAB QD or one packet of 4 mg oral granules QD. Age 6 months-2 years with asthma: One packet of 4 mg oral granules QD. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Hypersensitivity to any component of Singulair.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | Abdominal pain， headache， thirst， diarrhea， hyperkinesia， asthma， eczematous dermatitis， rash. Neurologic: Headache (Adult and adolescent; 18.4%; pediatric， 2% and greater )                                                                                                                                                                                                                                                                                                                                                              |
| Pregnancy          | No (limited) human data – probably compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

## Singulair 4mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OSIN4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Indications        | SINGULAIR is indicated in adult & pediatric patients 6 months of age & older for the prophylaxis & chronic treatment of asthma， including the prevention of day- & nighttime symptoms， the treatment of aspirin-sensitive asthmatic patients， & the prevention of exercise-induced bronchoconstriction. SINGULAIR is indicated in adults & pediatric patients 2 years of age & older for the relief of day- & nighttime symptoms of seasonal allergic rhinitis.                                                                                 |
| Dosing             | Should be taken once daily. For asthma， the dose should be taken in the evening. For seasonal allergic rhinitis， the time of administration may be individualized. Patients with both asthma & seasonal allergic rhinitis should take only 1 TAB daily in the evening. Asthma and/or seasonal allergic rhinitis- Age > or = 15 years: 10 mg QD. Age 6-14 years: One 5 mg chewable TAB QD. Age 2-5 years: One 4 mg chewable TAB QD or one packet of 4 mg oral granules QD. Age 6 months-2 years with asthma: One packet of 4 mg oral granules QD. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Hypersensitivity to any component of Singulair.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | Abdominal pain， headache， thirst， diarrhea， hyperkinesia， asthma， eczematous dermatitis， rash. Neurologic: Headache (Adult and adolescent; 18.4%; pediatric， 2% and greater )                                                                                                                                                                                                                                                                                                                                                              |
| Pregnancy          | No (limited) human data – probably compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

